Literature DB >> 26108575

Viewpoint: It is time to reconsider policy for population-based mammography screening.

Anne J Kearney1.   

Abstract

Breast cancer in women is an important cause of morbidity and mortality. Many countries in the Western world have widely promoted early detection through mammography screening and established population-based screening programs. Over the past 15 years, there has been growing debate about the benefits and harms of universal mammography screening. This article presents findings from the latest systematic review conducted by the Cochrane Collaboration and from the Canadian National Breast Screening Study 25-year follow up. The authors of both reports conclude there is no reliable evidence that population-based mammography screening reduces mortality, but there is good evidence of harm in the form of false positive findings, over-diagnosis and unnecessary treatment, and associated psychological distress. It is time for policymakers to discontinue universal population-based mammography screening and shift to a more selective approach to early detection.

Entities:  

Mesh:

Year:  2015        PMID: 26108575     DOI: 10.1057/jphp.2015.19

Source DB:  PubMed          Journal:  J Public Health Policy        ISSN: 0197-5897            Impact factor:   2.222


  25 in total

1.  Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study.

Authors:  Rebecca A Hubbard; Karla Kerlikowske; Chris I Flowers; Bonnie C Yankaskas; Weiwei Zhu; Diana L Miglioretti
Journal:  Ann Intern Med       Date:  2011-10-18       Impact factor: 25.391

Review 2.  The benefits and harms of breast cancer screening: an independent review.

Authors:  M G Marmot; D G Altman; D A Cameron; J A Dewar; S G Thompson; M Wilcox
Journal:  Br J Cancer       Date:  2013-06-06       Impact factor: 7.640

3.  Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program.

Authors:  Mette Kalager; Hans-Olov Adami; Michael Bretthauer; Rulla M Tamimi
Journal:  Ann Intern Med       Date:  2012-04-03       Impact factor: 25.391

4.  Evidence against breast self examination is not conclusive: what policymakers and health professionals need to know.

Authors:  Anne J Kearney; Michael Murray
Journal:  J Public Health Policy       Date:  2006       Impact factor: 2.222

5.  Long-term psychosocial consequences of false-positive screening mammography.

Authors:  John Brodersen; Volkert Dirk Siersma
Journal:  Ann Fam Med       Date:  2013 Mar-Apr       Impact factor: 5.166

6.  Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database.

Authors:  Philippe Autier; Mathieu Boniol; Anna Gavin; Lars J Vatten
Journal:  BMJ       Date:  2011-07-28

7.  Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials.

Authors:  R Peto; C Davies; J Godwin; R Gray; H C Pan; M Clarke; D Cutter; S Darby; P McGale; C Taylor; Y C Wang; J Bergh; A Di Leo; K Albain; S Swain; M Piccart; K Pritchard
Journal:  Lancet       Date:  2011-12-05       Impact factor: 79.321

8.  Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies.

Authors:  M Nielsen; J L Thomsen; S Primdahl; U Dyreborg; J A Andersen
Journal:  Br J Cancer       Date:  1987-12       Impact factor: 7.640

Review 9.  Screening for breast cancer with mammography.

Authors:  Peter C Gøtzsche; Karsten Juhl Jørgensen
Journal:  Cochrane Database Syst Rev       Date:  2013-06-04

10.  Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial.

Authors:  Anthony B Miller; Claus Wall; Cornelia J Baines; Ping Sun; Teresa To; Steven A Narod
Journal:  BMJ       Date:  2014-02-11
View more
  1 in total

1.  Epidemiological and sociodemographic transitions of female breast cancer incidence, death, case fatality and DALYs in 21 world regions and globally, from 1990 to 2017: An Age-Period-Cohort Analysis.

Authors:  Sumaira Mubarik; Yong Yu; Fang Wang; Saima Shakil Malik; Xiaoxue Liu; Muhammad Fawad; Fang Shi; Chuanhua Yu
Journal:  J Adv Res       Date:  2021-08-02       Impact factor: 12.822

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.